Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 195

1.

Clinical and Economic Effects of a Pharmacist-Administered Antiretroviral Therapy Adherence Clinic for Patients Living with HIV.

Dilworth TJ, Klein PW, Mercier RC, Borrego ME, Jakeman B, Pinkerton SD.

J Manag Care Spec Pharm. 2018 Feb;24(2):165-172. doi: 10.18553/jmcp.2018.24.2.165.

2.

Audit Culture: Unintended Consequences of Accountability Practices in Evidence-Based Programs.

Owczarzak J, Broaddus M, Pinkerton S.

Am J Eval. 2016 Sep;37(3):326-343. doi: 10.1177/1098214015603502. Epub 2015 Sep 4.

3.

Partnership-Level Analysis of African American Women's Risky Sexual Behavior in Main and Non-Main Partnerships.

Broaddus M, Owczarzak J, Pacella M, Pinkerton S, Wright C.

AIDS Behav. 2016 Dec;20(12):2893-2903. Review.

4.

A qualitative analysis of the concepts of fidelity and adaptation in the implementation of an evidence-based HIV prevention intervention.

Owczarzak J, Broaddus M, Pinkerton S.

Health Educ Res. 2016 Apr;31(2):283-94. doi: 10.1093/her/cyw012. Epub 2016 Mar 3.

5.

Are community-based pharmacists underused in the care of persons living with HIV? A need for structural and policy changes.

Kibicho J, Pinkerton SD, Owczarzak J, Mkandawire-Valhmu L, Kako PM.

J Am Pharm Assoc (2003). 2015 Jan-Feb;55(1):19-30. doi: 10.1331/JAPhA.2015.14107.

6.

Combined prevention for persons who inject drugs in the HIV epidemic in a transitional country: the case of Tallinn, Estonia.

Uusk├╝la A, Des Jarlais DC, Raag M, Pinkerton SD, Feelemyer J.

AIDS Care. 2015;27(1):105-11. doi: 10.1080/09540121.2014.940271. Epub 2014 Jul 23.

7.

Flutamide and biomarkers in women at high risk for ovarian cancer: preclinical and clinical evidence.

Gruessner C, Gruessner A, Glaser K, AbuShahin N, Zhou Y, Laughren C, Wright H, Pinkerton S, Yi X, Stoffer J, Azodi M, Zheng W, Chambers SK.

Cancer Prev Res (Phila). 2014 Sep;7(9):896-905. doi: 10.1158/1940-6207.CAPR-13-0408. Epub 2014 Jun 20.

8.

Syringe exchange in the United States: a national level economic evaluation of hypothetical increases in investment.

Nguyen TQ, Weir BW, Des Jarlais DC, Pinkerton SD, Holtgrave DR.

AIDS Behav. 2014 Nov;18(11):2144-55. doi: 10.1007/s10461-014-0789-9.

9.

Criminal HIV exposure laws: moving forward.

Galletly C, Lazzarini Z, Sanders C, Pinkerton SD.

AIDS Behav. 2014 Jun;18(6):1011-3. doi: 10.1007/s10461-014-0731-1. No abstract available.

10.

Community-Based Pharmacists' Needs for HIV-Related Training and Experience.

Kibicho J, Pinkerton SD, Owczarzak J.

J Pharm Pract. 2014 Aug;27(4):369-78. doi: 10.1177/0897190013513301. Epub 2013 Dec 10.

PMID:
24326410
11.

The teeth and faces of twins: providing insights into dentofacial development and oral health for practising oral health professionals.

Hughes TE, Townsend GC, Pinkerton SK, Bockmann MR, Seow WK, Brook AH, Richards LC, Mihailidis S, Ranjitkar S, Lekkas D.

Aust Dent J. 2014 Jun;59 Suppl 1:101-16. doi: 10.1111/adj.12101. Epub 2013 Oct 2. Review.

12.

30 Years on Selected Issues in the Prevention of HIV among Persons Who Inject Drugs.

Des Jarlais DC, Pinkerton S, Hagan H, Guardino V, Feelemyer J, Cooper H, Hatzatkis A, Uuskula A.

Adv Prev Med. 2013;2013:346372. doi: 10.1155/2013/346372. Epub 2013 Jun 12.

13.

Genetic, epigenetic, and environmental influences on dentofacial structures and oral health: ongoing studies of Australian twins and their families.

Hughes T, Bockmann M, Mihailidis S, Bennett C, Harris A, Seow WK, Lekkas D, Ranjitkar S, Rupinskas L, Pinkerton S, Brook A, Smith R, Townsend GC.

Twin Res Hum Genet. 2013 Feb;16(1):43-51. doi: 10.1017/thg.2012.78.

PMID:
23394189
14.

Cost analysis of enhancing linkages to HIV care following jail: a cost-effective intervention.

Spaulding AC, Pinkerton SD, Superak H, Cunningham MJ, Resch S, Jordan AO, Yang Z.

AIDS Behav. 2013 Oct;17 Suppl 2:S220-6. doi: 10.1007/s10461-012-0353-4.

15.

Is the US AIDS drug assistance program cost-effective?

Pinkerton SD, Kibicho J, Galletly CL.

AIDS Behav. 2013 Jan;17(1):1-4. doi: 10.1007/s10461-012-0321-z.

16.

New Jersey's HIV exposure law and the HIV-related attitudes, beliefs, and sexual and seropositive status disclosure behaviors of persons living with HIV.

Galletly CL, Glasman LR, Pinkerton SD, Difranceisco W.

Am J Public Health. 2012 Nov;102(11):2135-40. doi: 10.2105/AJPH.2012.300664. Epub 2012 Sep 20.

17.

Opinions of a small sample of pharmacists about pharmacy setting and patient adherence to antiretroviral therapy.

Kibicho J, Owczarzak J, Pinkerton SD.

J Manag Care Pharm. 2012 Jul-Aug;18(6):446-52. No abstract available.

18.

Multiple drug cost containment policies in Michigan's Medicaid program saved money overall, although some increased costs.

Kibicho J, Pinkerton SD.

Health Aff (Millwood). 2012 Apr;31(4):816-26. doi: 10.1377/hlthaff.2011.0246.

19.

Linearity and nonlinearity in HIV/STI transmission: implications for the evaluation of sexual risk reduction interventions.

Pinkerton SD, Chesson HW, Crosby RA, Layde PM.

Eval Rev. 2011 Oct;35(5):550-65. doi: 10.1177/0193841X11432196. Epub 2011 Dec 27.

20.

Diagnosis and treatment of minimal hepatic encephalopathy to prevent motor vehicle accidents: a cost-effectiveness analysis.

Bajaj JS, Pinkerton SD, Sanyal AJ, Heuman DM.

Hepatology. 2012 Apr;55(4):1164-71. doi: 10.1002/hep.25507.

21.

Heterosexual anal intercourse and HIV infection risks in the context of alcohol serving venues, Cape Town, South Africa.

Kalichman SC, Pinkerton SD, Carey MP, Cain D, Mehlomakulu V, Carey KB, Simbayi LC, Mwaba K, Harel O.

BMC Public Health. 2011 Oct 14;11:807. doi: 10.1186/1471-2458-11-807.

22.

HIV transmission rate modeling: a primer, review, and extension.

Pinkerton SD.

AIDS Behav. 2012 May;16(4):791-6. doi: 10.1007/s10461-011-0042-8. Review.

23.

A quantitative study of Michigan's criminal HIV exposure law.

Galletly CL, Pinkerton SD, DiFranceisco W.

AIDS Care. 2012;24(2):174-9. doi: 10.1080/09540121.2011.603493. Epub 2011 Aug 23.

24.

How many HIV infections are prevented by Vancouver Canada's supervised injection facility?

Pinkerton SD.

Int J Drug Policy. 2011 May;22(3):179-83. doi: 10.1016/j.drugpo.2011.03.003. Epub 2011 Mar 29.

PMID:
21450450
25.

A conceptual model of interventions to increase diagnosis of acute HIV infection and reduce forward transmission.

Petroll AE, Pinkerton SD.

AIDS Behav. 2011 Nov;15(8):1715-20. doi: 10.1007/s10461-010-9867-9. No abstract available.

26.

Internet use, recreational travel, and HIV risk behaviors in men who have sex with men.

Benotsch EG, Martin AM, Espil FM, Nettles CD, Seal DW, Pinkerton SD.

J Community Health. 2011 Jun;36(3):398-405. doi: 10.1007/s10900-010-9321-y.

27.

Sexual health curricula in U.S. medical schools: current educational objectives.

Galletly C, Lechuga J, Layde JB, Pinkerton S.

Acad Psychiatry. 2010 Sep-Oct;34(5):333-8. doi: 10.1176/appi.ap.34.5.333.

PMID:
20833900
28.

Is Vancouver Canada's supervised injection facility cost-saving?

Pinkerton SD.

Addiction. 2010 Aug;105(8):1429-36. doi: 10.1111/j.1360-0443.2010.02977.x.

PMID:
20653622
29.

Cost of rapid HIV testing at 45 U.S. hospitals.

Pinkerton SD, Bogart LM, Howerton D, Snyder S, Becker K, Asch SM.

AIDS Patient Care STDS. 2010 Jul;24(7):409-13. doi: 10.1089/apc.2009.0348.

30.

Aggregate versus individual-level sexual behavior assessment: how much detail is needed to accurately estimate HIV/STI risk?

Pinkerton SD, Galletly CL, McAuliffe TL, DiFranceisco W, Raymond HF, Chesson HW.

Eval Rev. 2010 Feb;34(1):19-34. doi: 10.1177/0193841X09353534.

31.

Cost of OraQuick oral fluid rapid HIV testing at 35 community clinics and community-based organizations in the USA.

Pinkerton SD, Bogart LM, Howerton D, Snyder S, Becker K, Asch SM.

AIDS Care. 2009 Sep;21(9):1157-62. doi: 10.1080/09540120902729940.

PMID:
20024775
32.

Lessons learned about behavioral science and acute/early HIV infection. The NIMH Multisite Acute HIV Infection Study: V.

Kelly JA, Morin SF, Remien RH, Steward WT, Higgins JA, Seal DW, Dubrow R, Atkinson JH, Kerndt PR, Pinkerton SD, Mayer K, Sikkema KJ.

AIDS Behav. 2009 Dec;13(6):1068-74. doi: 10.1007/s10461-009-9579-1. Epub 2009 Jun 6.

33.

Behavior change following diagnosis with acute/early HIV infection-a move to serosorting with other HIV-infected individuals. The NIMH Multisite Acute HIV Infection Study: III.

Steward WT, Remien RH, Higgins JA, Dubrow R, Pinkerton SD, Sikkema KJ, Truong HM, Johnson MO, Hirsch J, Brooks RA, Morin SF.

AIDS Behav. 2009 Dec;13(6):1054-60. doi: 10.1007/s10461-009-9582-6. Epub 2009 Jun 6.

34.

Advancing the profession: how will we do it?

Pinkerton S.

Nurs Econ. 2009 Mar-Apr;27(2):131-3.

PMID:
19492779
35.

Seriously mentally ill women's safer sex behaviors and the theory of reasoned action.

Randolph ME, Pinkerton SD, Somlai AM, Kelly JA, McAuliffe TL, Gibson RH, Hackl K.

Health Educ Behav. 2009 Oct;36(5):948-58. doi: 10.1177/1090198108324597. Epub 2009 May 20.

36.

The Unit Practice Council: center of professional practice.

Pinkerton S.

Nurs Econ. 2008 Nov-Dec;26(6):401-3.

PMID:
19330977
37.

HIV testing rates, testing locations, and healthcare utilization among urban African-American men.

Petroll AE, DiFranceisco W, McAuliffe TL, Seal DW, Kelly JA, Pinkerton SD.

J Urban Health. 2009 Jan;86(1):119-31. doi: 10.1007/s11524-008-9339-y. Epub 2008 Dec 9.

38.
39.

HIV-positive persons' awareness and understanding of their state's criminal HIV disclosure law.

Galletly CL, Difranceisco W, Pinkerton SD.

AIDS Behav. 2009 Dec;13(6):1262-9. doi: 10.1007/s10461-008-9477-y. Epub 2008 Oct 31.

40.
41.

Inhibitory control test for the diagnosis of minimal hepatic encephalopathy.

Bajaj JS, Hafeezullah M, Franco J, Varma RR, Hoffmann RG, Knox JF, Hischke D, Hammeke TA, Pinkerton SD, Saeian K.

Gastroenterology. 2008 Nov;135(5):1591-1600.e1. doi: 10.1053/j.gastro.2008.07.021. Epub 2008 Jul 22.

PMID:
18723018
42.

The essentials of HIV: a review for nurses.

Petroll AE, Hare CB, Pinkerton SD.

J Infus Nurs. 2008 Jul-Aug;31(4):228-35. doi: 10.1097/01.NAN.0000326831.82526.c4. Review.

43.

Acute HIV infection increases the dangers of serosorting.

Pinkerton SD.

Am J Prev Med. 2008 Aug;35(2):184. doi: 10.1016/j.amepre.2008.04.012. No abstract available.

44.

The Magnet view: celebrating the Magnet way.

Pinkerton S.

Nurs Econ. 2008 May-Jun;26(3):193-4.

PMID:
18616059
45.

Updated CDC guidelines for HIV testing: a review for Wisconsin practitioners.

Petroll AE, Galletly CL, Havens PL, Kwiecinski MF, Pinkerton SD.

WMJ. 2008 Apr;107(2):84-90. Review.

46.

Model-Based Estimates of HIV Acquisition Due to Prison Rape.

Pinkerton SD, Galletly CL, Seal DW.

Prison J. 2007;87(3):295-310.

47.

Proposal for the development of a standardized protocol for assessing the economic costs of HIV prevention interventions.

Pinkerton SD, Pearson CR, Eachus SR, Berg KM, Grimes RM.

J Acquir Immune Defic Syndr. 2008 Mar 1;47 Suppl 1:S10-4. doi: 10.1097/QAI.0b013e3181605a98.

48.

CDC recommendations for opt-out testing and reactions to unanticipated HIV diagnoses.

Galletly CL, Pinkerton SD, Petroll AE.

AIDS Patient Care STDS. 2008 Mar;22(3):189-93. doi: 10.1089/apc.2007.0104.

49.

Infections prevented by increasing HIV serostatus awareness in the United States, 2001 to 2004.

Pinkerton SD, Holtgrave DR, Galletly CL.

J Acquir Immune Defic Syndr. 2008 Mar 1;47(3):354-7. doi: 10.1097/QAI.0b013e318160d57e.

50.

Probability of HIV transmission during acute infection in Rakai, Uganda.

Pinkerton SD.

AIDS Behav. 2008 Sep;12(5):677-84. Epub 2007 Dec 7.

Supplemental Content

Loading ...
Support Center